Loading clinical trials...
Loading clinical trials...
A Phase IIb Randomised, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety and Tolerability of AZD6234 compared with placebo, given once a week as subcutaneous injection for 36 we...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
AstraZeneca
NCT06937086 · Ulcerative Colitis, Obesity or Overweight
NCT07351045 · Obesity or Overweight
NCT07255209 · Adolescents With Obesity or Overweight With Weight-Related Comorbidities
NCT07128888 · Obesity or Overweight
NCT06862791 · Obesity or Overweight
Research Site
Mobile, Alabama
Research Site
Phoenix, Arizona
Research Site
Long Beach, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions